TriSalus Life Sciences, Inc.·4

May 18, 4:42 PM ET

Wahlstrom Mats 4

4 · TriSalus Life Sciences, Inc. · Filed May 18, 2026

Research Summary

AI-generated summary of this filing

Updated

TriSalus (TLSI) Director Mats Wahlstrom Buys 60,000 Shares

What Happened
Mats Wahlstrom, a director of TriSalus Life Sciences, acquired 60,000 common shares in open-market purchases on May 15, 2026. The weighted-average price was $2.53 per share, for a total reported outlay of approximately $151,800. This was a purchase (insider buy), which investors often view as more informative than routine sales.

Key Details

  • Transaction date: 2026-05-15 (Form 4 filed 2026-05-18; filing appears timely).
  • Transaction type/code: Open-market purchase (P).
  • Shares acquired: 60,000 at a weighted-average price of $2.53; total ~ $151,800.
  • Price range: purchases executed at $2.52–$2.56 per share (weighted average shown).
  • Shares owned after transaction: Not specified in the information provided in this summary.
  • Footnotes of note:
    • F1: Weighted-average price; reporter can provide breakdown of purchases by exact price on request.
    • F2: Wahlstrom shares voting and investment discretion with his spouse for shares held by Leonard Capital LLC.
    • F3: Wahlstrom is managing member of HW Investment Partners, LLC, shares voting/investment discretion for HW Investment-held shares, and disclaims beneficial ownership except to the extent of his pecuniary interest.

Context
This filing reports a straightforward open-market buy (no option exercise, gift, or 10b5-1 plan disclosed). Purchases by corporate insiders are often watched by retail investors as a potential signal of confidence, but the filing itself does not state the insider’s motivations.

Insider Transaction Report

Form 4
Period: 2026-05-15
Transactions
  • Purchase

    Common Stock

    [F1]
    2026-05-15$2.53/sh+60,000$151,800147,555 total
Holdings
  • Common Stock

    [F2]
    (indirect: By LLC)
    1,444,447
  • Common Stock

    [F3]
    (indirect: By LLC)
    1,370,028
Footnotes (3)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.52 to $2.56 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
  • [F2]The Reporting Person shares voting and investment discretion with his spouse with respect to the shares held directly by Leonard Capital LLC.
  • [F3]The Reporting Person is a managing member of HW Investment Partners, LLC ("HW Investment") and shares voting and investment discretion with respect to the shares held directly by HW Investment. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
Signature
/s/ Mary Szela, Attorney-in-Fact|2026-05-18

Documents

1 file
  • 4
    wk-form4_1779136958.xmlPrimary

    FORM 4